Patents by Inventor Michael Noldner

Michael Noldner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080124410
    Abstract: The present invention relates to the prophylactic and therapeutic use of lavender oil for the treatment of neurasthenia, somatization disorders and other stress-associated diseases as well as medicaments, dietetic food products, preparations and capsules containing lavender oil as oral administration forms.
    Type: Application
    Filed: October 5, 2005
    Publication date: May 29, 2008
    Inventors: Angelika Dienel, Michael Noldner
  • Publication number: 20070014877
    Abstract: The present invention relates to the use of extracts from Pelargonium species or plant parts thereof, particularly from P. sidoides and P. reniforme for the prophylaxis or treatment of disease-related behavioural changes, the chronic or post-viral asthenia syndrome and/or stress-induced chronic pathological conditions as well as pharmaceutical preparations containing these extracts.
    Type: Application
    Filed: October 26, 2004
    Publication date: January 18, 2007
    Applicant: ISO ARZNEIMITTEL GBMBH & CO. KG
    Inventors: Shyam Chatterjee, Egon Kach, Michael Noldner
  • Patent number: 6022889
    Abstract: The invention suggests a novel medical use of pure bilobalide or Ginkgo biloba extract with an increased bilobalide content as an anxiolytic or antidepressant.
    Type: Grant
    Filed: July 14, 1994
    Date of Patent: February 8, 2000
    Assignee: William Schwabe GmbH & Co.
    Inventors: Michael Noldner, Shyam S. Chatterjee
  • Patent number: 5428038
    Abstract: Novel 2H-1-benzopyran-2-ones (coumarin derivatives) of the general formula (I) are provided: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, X and Y are defined as in the specification, and the addition compounds thereof with physiologically compatible acids, intermediates and methods for the preparation thereof. The coumarin compounds possess a neuroprotective and anti-allergic action.
    Type: Grant
    Filed: October 8, 1993
    Date of Patent: June 27, 1995
    Assignee: Dr. Willmar Schwabe GmbH & Co.
    Inventors: Shyam S. Chatterjee, Michael Noldner, Hermann Hauer, Egon Koch